Skip to content
Clinical Trials – home

Kaiserswerther Diakonie

Research site

Germany Kreuzbergstrasse 79, Kaiserswerth, 40489 Duesseldorf, Germany

  • 5 trials recruiting
  • Non-small cell lung cancer · Ovarian cancer · Fallopian tube cancer
  • Adults and children

About Specializations

Kaiserswerther Diakonie in Duesseldorf, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Ovarian cancer, Fallopian tube cancer, Non-small cell lung cancer stage IV, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Thoracic Oncology Research

At Kaiserswerther Diakonie in Duesseldorf, clinical research in pneumology includes studies focused on neoplasms, especially non-small cell lung cancer in patients with resectable stage II and III disease. The trials are designed to assess the value of perioperative treatment approaches and to better understand whether they can improve outcomes for people undergoing surgery.

  • Evaluating treatment effectiveness in resectable NSCLC
  • Measuring event-free survival and overall survival
  • Testing whether adding a new therapy can support better cancer control around surgery

These studies reflect a strong interest in improving care for patients with surgically treatable lung cancer through more effective oncology strategies.

Digestive System Diseases and Postoperative Recovery Studies

The site also conducts research in digestive system diseases, with a focus on gastrointestinal recovery after abdominal surgery such as longitudinal laparotomy. This work aims to reduce postoperative discomfort and support a smoother return of bowel function after surgery.

  • Studying prevention of gastrointestinal disturbance after abdominal surgery
  • Assessing approaches to reduce postoperative ileus
  • Exploring whether an oral treatment can improve recovery and patient comfort

Research in this area is centered on improving postoperative care and helping patients recover more comfortably after major abdominal procedures.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Kreuzbergstrasse 79, Kaiserswerth40489 DuesseldorfGermany
Recruiting now
5 trials
Conditions studied
20

More sites in DuesseldorfGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

12 clinical trials

Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE

Study on Osimertinib and Chemotherapy for Stage IV Non-Small Cell Lung Cancer with Atypical EGFR Mutations

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Heidelberg University

Comparison of niraparib alone versus niraparib with bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH

Study on Niraparib, Carboplatin, and Paclitaxel for Advanced Ovarian Cancer Patients After Tumor Removal

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Nord Ostdeutsche Gesellschaft Fuer Gynaekologische Onkologie e.V.

Endometrial cancer

Not yet recruiting

Study of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:GSK5733584
  • Sponsor:Glaxosmithkline Research & Development Limited

Ovarian cancer

Not recruiting

Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AstraZeneca AB

Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Shanghai Henlius Biotech Inc.

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Laparotomy

Not recruiting

Study on Oral Lidocaine for Reducing Gastrointestinal Issues in Patients After Abdominal Surgery

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lidocaine Hydrochloride Monohydrate
  • Sponsor:Orexa B.V.

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Germ cell cancer

Not recruiting

Study Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:Rheinische Friedrich-Wilhelms-Universitaet Bonn
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.